Wolfgang R. Sperr

35.3k total citations · 2 hit papers
413 papers, 18.6k citations indexed

About

Wolfgang R. Sperr is a scholar working on Hematology, Immunology and Immunology and Allergy. According to data from OpenAlex, Wolfgang R. Sperr has authored 413 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Hematology, 143 papers in Immunology and 84 papers in Immunology and Allergy. Recurrent topics in Wolfgang R. Sperr's work include Mast cells and histamine (128 papers), Acute Myeloid Leukemia Research (109 papers) and Food Allergy and Anaphylaxis Research (69 papers). Wolfgang R. Sperr is often cited by papers focused on Mast cells and histamine (128 papers), Acute Myeloid Leukemia Research (109 papers) and Food Allergy and Anaphylaxis Research (69 papers). Wolfgang R. Sperr collaborates with scholars based in Austria, Germany and United States. Wolfgang R. Sperr's co-authors include Peter Valent, Rudolf Valenta, Klaus Lechner, Ulrich Schoop, Kawe Goharkhay, Hans‐Peter Horny, Dietrich Kraft, Andreas Moritz, Cem Akin and Christian Sillaber and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Wolfgang R. Sperr

405 papers receiving 17.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic criteria and classification of mastocytosis: a consensus proposal

2001 738 citations Peter Valent, Cem Akin et al. Leukemia Research profile →
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

2012 457 citations Peter Valent, Hans‐Peter Horny et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wolfgang R. Sperr Austria	71	6.7k	5.4k	3.7k	3.7k	3.0k	413	18.6k
Steffen Gay Switzerland	103	8.1k 1.2×	3.0k 0.6×	2.8k 0.8×	11.6k 3.1×	13.8k 4.6×	523	36.4k
Hideaki Nagase United States	88	3.0k 0.4×	4.3k 0.8×	5.9k 1.6×	4.4k 1.2×	10.2k 3.4×	297	33.0k
Ghislain Opdenakker Belgium	91	9.4k 1.4×	3.4k 0.6×	3.3k 0.9×	1.8k 0.5×	9.5k 3.2×	512	30.1k
Gillian Murphy United Kingdom	110	3.1k 0.5×	7.0k 1.3×	7.5k 2.0×	4.1k 1.1×	12.3k 4.1×	314	38.0k
Tuula Salo Finland	80	1.6k 0.2×	2.1k 0.4×	1.3k 0.4×	1.4k 0.4×	5.6k 1.9×	477	22.9k
Daniel B. Rifkin United States	92	3.0k 0.4×	4.4k 0.8×	2.9k 0.8×	1.4k 0.4×	17.5k 5.9×	230	32.7k
Timo Sorsa Finland	84	2.0k 0.3×	1.2k 0.2×	1.5k 0.4×	1.7k 0.5×	4.0k 1.4×	581	26.1k
Christopher D. Buckley United Kingdom	81	8.7k 1.3×	2.1k 0.4×	2.5k 0.7×	5.2k 1.4×	6.3k 2.1×	388	22.5k
Robert M. Senior United States	76	3.4k 0.5×	2.5k 0.5×	2.3k 0.6×	1.3k 0.3×	5.3k 1.8×	192	21.0k
Gregory R. Mundy United States	105	2.7k 0.4×	1.5k 0.3×	2.8k 0.7×	4.0k 1.1×	18.7k 6.3×	335	37.2k

Countries citing papers authored by Wolfgang R. Sperr

Since Specialization

Citations

This map shows the geographic impact of Wolfgang R. Sperr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang R. Sperr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang R. Sperr more than expected).

Fields of papers citing papers by Wolfgang R. Sperr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang R. Sperr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang R. Sperr. The network helps show where Wolfgang R. Sperr may publish in the future.

Co-authorship network of co-authors of Wolfgang R. Sperr

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang R. Sperr. A scholar is included among the top collaborators of Wolfgang R. Sperr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang R. Sperr. Wolfgang R. Sperr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reiter, Andreas, Jason Gotlib, Iván Álvarez‐Twöse, et al.. (2025). Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control study. Leukemia Research. 157. 107919–107919.

Sadovnik, Irina, Barbara Peter, Gabriele Stefanzl, et al.. (2024). Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils. Cells. 13(2). 173–173. 5 indexed citations

Bauer, Karin, Alexander W. Hauswirth, Karoline V. Gleixner, et al.. (2024). BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL. American Journal of Hematology. 99(9). 1721–1731. 15 indexed citations

Schrottmaier, Waltraud C., Hubert Hackl, Sarah Beck, et al.. (2024). Impaired hemostatic and immune functions of platelets after acute thrombocytopenia. Journal of Thrombosis and Haemostasis. 23(3). 1052–1065. 1 indexed citations

Greiner, Georg, Rodrig Marculescu, Karoline V. Gleixner, et al.. (2023). N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia. American Journal of Hematology. 98(2). 290–299. 5 indexed citations

Valent, Peter, Irina Sadovnik, Barbara Peter, et al.. (2023). Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives. Expert Review of Hematology. 16(9). 659–670.

Valent, Peter, Cem Akin, Michel Arock, et al.. (2023). Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts. International Journal of Molecular Sciences. 24(20). 15125–15125. 1 indexed citations

Toma, Monika M., Margaret Nieborowska-Skorska, Marie‐Christine Caron, et al.. (2023). Inactivation of DNA Polymerase Theta (PolΘ) Is Synthetic Lethal in DNMT3A Mutated Myeloid Malignancies - Potential Clinical Applications. Blood. 142(Supplement 1). 580–580. 1 indexed citations

Valent, Peter, Cem Akin, Karin Hartmann, et al.. (2022). Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?. Journal of Allergy and Clinical Immunology. 149(6). 1866–1874. 17 indexed citations

10.

Heinemann, Tim, Christoph Kornauth, Yannik Severin, et al.. (2022). Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine. Blood Cancer Discovery. 3(6). 502–515. 11 indexed citations

11.

Gleixner, Karoline V., Daniela Berger, Gabriele Stefanzl, et al.. (2021). Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations. American Journal of Cancer Research. 11(9). 4470–4484. 28 indexed citations

12.

Boehm, Thomas, Birgit Reiter, Robin Ristl, et al.. (2018). Massive release of the histamine‐degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients. Allergy. 74(3). 583–593. 41 indexed citations

13.

Greiner, Georg, Franz Ratzinger, Nadine Witzeneder, et al.. (2017). Digital Droplet PCR: Next Generation KIT D816V Testing As Advanced Tool for Diagnosis and Prognostication in Mastocytosis. Blood. 130. 2927–2927. 1 indexed citations

14.

Valent, Peter, Emir Hadzijusufovic, Gregor Hoermann, et al.. (2017). Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML. Leukemia Research. 59. 47–54. 47 indexed citations

15.

Blatt, Katharina, Harald Herrmann, Gregor Hoermann, et al.. (2014). Identification of Campath-1 (CD52) as Novel Drug Target in Neoplastic Stem Cells in 5q-Patients with MDS and AML. Clinical Cancer Research. 20(13). 3589–3602. 23 indexed citations

16.

Swoboda, Ines, Nicole A. de Weerd, Prem L. Bhalla, et al.. (2002). Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy. European Journal of Immunology. 32(1). 270–280. 63 indexed citations

17.

Moritz, Andreas, Ulrich Schoop, Kawe Goharkhay, et al.. (1999). The Bactericidal Effect of Nd:YAG, Ho:YAG, and Er:YAG Laser Irradiation in the Root Canal: An in Vitro Comparison. Journal of Clinical Laser Medicine & Surgery. 17(4). 161–164. 92 indexed citations

18.

Moritz, Andreas, et al.. (1997). Irradiation of infected root canals with a diode laser in vivo: Results of microbiological examinations. Lasers in Surgery and Medicine. 21(3). 221–226. 80 indexed citations

19.

Agis, Hermine, Wolfgang Füreder, Hans Bankl, et al.. (1996). Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology. 87(4). 535–543. 117 indexed citations

20.

Agis, Hermine, Martin Willheim, Wolfgang R. Sperr, et al.. (1993). Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c- kit +, CD34+, Ly-, CD14-, CD17-, colony-forming cell.. The Journal of Immunology. 151(8). 4221–4227. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact